UCB turns to Belgian retail market again, for up to €250m
UCB, the unrated Belgian pharmaceutical company, will on Monday begin selling a domestic retail bond issue of €100m to €250m.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts